Zydus Lifesciences shares were trading flat on October 18 after the company received final approval to manufacture ...

ICMR partners with Zydus Lifesciences for Desidustat phase-2 trials in sickle cell disease patients, aiming for innovative ...

Delhi HC reinstates injunction on Zydus, halting sale of breast cancer drug Sigrima: Shardul Nautiyal, Mumbai Friday, October 18, 2024, 18:15 Hrs [IST] In another significant setb ...

The Delhi High Court division bench has allowed Zydus Lifesciences to sell its breast cancer drug Sigrima amidst accusations ...

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to manufacture its ...

The Indian Council of Medical Research (ICMR) on Monday announced a partnership with domestic pharma giant Zydus Lifesciences ...

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Fludrocortisone Acetate Tablets USP, 0.1 mg (USRLD: Florinef Tablets, 0.1 mg).

Focus on handholding patients through the disease cycle, a large pipeline of 300-plus molecules put Zydus ahead of the rest.

On Sept. 13, Zydus Lifesciences signed a pact with US-based Viwit Pharmaceuticals for two MRI injectables and contrast agents. The pact has been inked for gadobutrol injection, a generic version of ...

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as "Zydus") has received ...

Zydus Lifesciences has received USFDA approval to manufacture generic Paliperidone extended-release tablets, used to treat ...